Page last updated: 2024-08-23

staurosporine and Diffuse Large B-Cell Lymphoma

staurosporine has been researched along with Diffuse Large B-Cell Lymphoma in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (70.00)18.2507
2000's3 (30.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, X; Lossos, IS; Lu, X; Malumbres, R; Natkunam, Y; Sarosiek, KA; Shields, B; Tiganis, T1
Aguilera, N; Auerbach, A; Burger, AM; D'Costa, AM; Jiang, F; Rapoport, AP; Sands, AM; Sausville, EA; Stass, SA; Zhao, MY; Zhao, XF1
Chorváth, B; Hunáková, L; Sedlák, J; Sulíková, M1
Atkins, KB; Troen, BR1
Geberhiwot, T; Skoglund, G1
Clark, C; Foxwell, B; Gammon, G; Hill, S; Hughes, A; Mander, T; Moore, M; Rawlins, P1
Arbuck, SG; Bauer, KS; Figg, WD; Fuse, E; Headlee, D; Jaken, S; Jing , X; Kuwabara, T; Lahusen, T; Lush, RM; Messmann, R; Murgo, A; Roberge, M; Sausville, EA; Senderowicz, AM1
Brakebusch, C; Holtmann, H; Klocke, R; König, M; Resch, K; Wallach, D; Winzen, R1
Goppelt-Strübe, M; Gunji, H; Hartmann, A; Hass, R; Hidaka, H; Kharbanda, S; Kufe, D; Meyer, G; Pfannkuche, HJ; Resch, K1
Jhaveri, S; Laurence, J; Salmon, JE; Sikder, SK1

Trials

1 trial(s) available for staurosporine and Diffuse Large B-Cell Lymphoma

ArticleYear
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-15, Volume: 19, Issue:8

    Topics: Adult; Aged; Alkaloids; Antineoplastic Agents; DNA Damage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hyperglycemia; Hypotension; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Nausea; Neoplasms; Skin Neoplasms; Staurosporine; Vomiting

2001

Other Studies

9 other study(ies) available for staurosporine and Diffuse Large B-Cell Lymphoma

ArticleYear
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
    Blood, 2008, Nov-15, Volume: 112, Issue:10

    Topics: Animals; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Inflammation; Interleukin-4; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Knockout; Mutation, Missense; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA, Messenger; Signal Transduction; STAT5 Transcription Factor; STAT6 Transcription Factor; Staurosporine; Tumor Suppressor Proteins; TYK2 Kinase

2008
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Mar-01, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Proliferation; Cyclin B; Cyclin-Dependent Kinases; Drug Synergism; Female; Flow Cytometry; G1 Phase; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Sirolimus; Staurosporine; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2009
Differential effect of protein kinase inhibitors (staurosporine and CGP 41,251) on TPA-induced homotypic aggregation and cell surface adhesion antigen expression in human monoblastoid cell line U-937.
    Neoplasma, 1995, Volume: 42, Issue:4

    Topics: Alkaloids; Cell Aggregation; Humans; Intercellular Adhesion Molecule-1; Lymphoma, Large B-Cell, Diffuse; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1995
Phorbol ester stimulated cathepsin L expression in U937 cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1995, Volume: 6, Issue:6

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Cathepsin L; Cathepsins; Cell Differentiation; Cycloheximide; Cysteine Endopeptidases; Drug Interactions; Endopeptidases; Enzyme Induction; Humans; Isoquinolines; Lymphoma, Large B-Cell, Diffuse; Monocytes; Neoplasm Proteins; Piperazines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vanadates

1995
Ectoprotein kinase activities on non-differentiated and differentiated U-937 cells.
    Cellular signalling, 1995, Volume: 7, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Alkaloids; Calcium; Carcinogens; Cell Differentiation; Cyclic AMP; Enzyme Inhibitors; Humans; Isoquinolines; Lymphoma, Large B-Cell, Diffuse; Oligopeptides; Phosphorylation; Phosvitin; Piperazines; Protein Kinase C; Protein Kinases; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1995
Differential effects on TNF alpha production by pharmacological agents with varying molecular sites of action.
    International journal of immunopharmacology, 1997, Volume: 19, Issue:8

    Topics: Benzoquinones; Binding Sites; Calcium-Calmodulin-Dependent Protein Kinases; Dexamethasone; Enzyme Activation; Enzyme Inhibitors; Humans; Interleukin-10; Interleukin-4; Lactams, Macrocyclic; Lipopolysaccharides; Lymphoma, Large B-Cell, Diffuse; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monocytes; Quinones; Rifabutin; Signal Transduction; Staurosporine; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1997
Mechanisms controlling the level of receptors for tumor necrosis factor.
    Agents and actions, 1991, Volume: 32, Issue:1-2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alkaloids; Enzyme Activation; Fibroblasts; HeLa Cells; Humans; Interleukin-1; Lymphoma, Large B-Cell, Diffuse; Protein Kinase C; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1991
Protein kinase C activation and protooncogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1991, Volume: 2, Issue:11

    Topics: Alkaloids; Biomarkers, Tumor; Cell Differentiation; Cytokines; Enzyme Activation; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Large B-Cell, Diffuse; Monocytes; Neoplasm Proteins; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogenes; RNA, Messenger; RNA, Neoplasm; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1991
Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation.
    Biochemical and biophysical research communications, 1990, Jan-15, Volume: 166, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 2-Aminopurine; Adenine; Alkaloids; Cell Line; Clone Cells; Gene Products, tat; HIV-1; Humans; Idoxuridine; Isoquinolines; Lymphoma, Large B-Cell, Diffuse; Piperazines; Protein Kinase Inhibitors; Staurosporine; tat Gene Products, Human Immunodeficiency Virus; Tetradecanoylphorbol Acetate; Trans-Activators; Transcriptional Activation; Virus Replication

1990